34.00p+0.25 (+0.74%)22 Jul 2025, 17:07
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Avacta Group PLC Fundamentals

Company NameAvacta Group PLCLast Updated2025-07-22
IndustryBiotechnologySectorHealthcare
Shares in Issue387.006 mMarket Cap£131.58 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.15EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.4751Debt Equity Ratio0.1597
Asset Equity Ratio5.2009Cash Equity Ratio1.3870
Quick Ratio0.3528Current Ratio1.08
Price To Book Value14.0647ROCE0

Avacta Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Avacta Group PLC Company Financials

Assets202420232022
Tangible Assets£2.79 m£9.99 m£7.80 m
Intangible Assets£1.84 m£30.84 m£26.32 m
Investments£3.44 m£4.08 m£2.98 m
Total Fixed Assets£8.07 m£45.16 m£37.37 m
Stocks0£2.58 m£1.68 m
Debtors£286,000.00£4.49 m£3.72 m
Cash & Equivalents£12.87 m£16.63 m£41.78 m
Other Assets0£253,000.00£274,000.00
Total Assets£48.27 m£73.19 m£92.92 m
Liabilities202420232022
Creditors within 1 year£37.30 m£50.01 m£67.61 m
Creditors after 1 year£1.69 m£6.28 m£4.32 m
Other Liabilities£8.69 m00
Total Liabilities£38.99 m£56.29 m£71.93 m
Net assets£9.28 m£16.90 m£21.00 m
Equity202420232022
Called up share capital£36.94 m£28.42 m£26.61 m
Share Premium£115.58 m£83.41 m£62.18 m
Profit / Loss-£28.98 m-£31.13 m-£41.64 m
Other Equity£9.28 m£16.90 m£21.00 m
Preference & Minorities000
Total Capital Employed£9.28 m£16.90 m£21.00 m
Ratios202420232022
Debt Ratio£0.14£0.26£0.15
Debt-to-Equity£0.16£0.35£0.18
Assets / Equity5.20095.20095.2009
Cash / Equity1.38701.38701.3870
EPS-£0.11-£0.13-£0.11
Cash Flow202420232022
Cash from operating activities-£23.60 m-£14.87 m-£16.43 m
Cashflow before financing£2.50 m-£16.17 m£40.47 m
Increase in Cash£1.07 m-£25.17 m£15.43 m
Income202420232022
Turnover£113,000.00£2.85 m£9.65 m
Cost of sales0£15,000.00£2.41 m
Gross Profit£113,000.00£2.84 m£7.24 m
Operating Profit-£32.56 m-£23.13 m-£32.65 m
Pre-Tax profit-£28.98 m-£31.13 m-£41.64 m

Avacta Group PLC Company Background

SectorHealthcare
ActivitiesAvacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessingits proprietary technology. Geographically, it derives revenue from South Korea.
Latest Interim Date30 Sep 2024
Latest Fiscal Year End Date6 Jun 2025

Avacta Group PLC Directors

AppointedNamePosition
2025-06-07Ms. Darlene Marie Deptula-HicksNon-Executive Director
2025-06-07Dr. Trevor John Nicholls Non-Executive Director
2011-12-15Dr. Barry PorterNon-Executive Director
2015-01-23Dr. Gwynfor Owen HumphreysNon-Executive Director
2024-06-03Professor Dr. David Alastair MacLaughlin Smith Executive Director,Chief Executive Officer
2019-01-21Mr. Alan John AubreyNon-Executive Director
2024-06-26Mr. Tony Peter GardinerExecutive Director,Chief Financial Officer and Company Secretary
2016-12-02Mr. Timothy James SykesExecutive Director,Chief Financial Officer and Co Secretary
2014-01-24Professor Anthony William Robards, OBENon-Executive Director
2017-12-05Mr. Craig SlaterExecutive Director,Chief Operating Officer
2005-04-30Mr. Kui Man YeungNon-Executive Director
2011-08-09Dr. Simon Webster, PhDExecutive Director,Chief Scientific Officer
2011-08-09Dr. Kurt Justin Baldwin, M.Sc.,PhDExecutive Director,Chief Technology Officer
2011-08-09Mr. Russell Winston HodgettsExecutive Director,Chief Operating Officer
2024-05-31Mr. Shaun Edward ChiltonNon-Executive Director,Chairman
2018-03-29Dr. Michael Scott AlbinNon-Executive Director
2019-11-04Dr. Samuel Cameron Williams Non-Executive Director
2021-03-25Dr. Michael John OwenNon-Executive Director,Senior Independent Director
2024-06-20Dr. Eliot Richard Forster, M.B.A.,PhDNon-Executive Director,Chairman
2024-05-31Mr. Paul Andrew Fry Non-Executive Director
2025-06-07Dr. Christina Marie CoughlinExecutive Director,Chief Executive Officer

Avacta Group PLC Contact Details

Company NameAvacta Group PLC
AddressUnit 20, Ash Way, Thorp Arch Estate, Wetherby, LS23 7FA
Telephone+44 1904217070
Websitehttps://avacta.com

Avacta Group PLC Advisors

StockbrokerWG Partners
StockbrokerFinnCap
Phone+44 2072200500
Fax+44 2076001659
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2076001659
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
AuditorKPMG
Phone+44 1132313000
Fax+44 1132313200
SolicitorWalker Morris
Phone+44 1132832500
Fax+44 1132459412
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342